SVRA$4.731.97%-0.095
After Hours: 4.75+0.03 +0.53%
Savara Inc (SVRA)
Date: 2026-11-02 16:00O: 4.83H: 4.91L: 4.67C: 4.73Vol: 1.778M
Savara Inc stock is traded at $4.73, with a volume of 1,432,267. It is down -1.97% in the last 24 hours and down -1.77% over the past month. Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Previous Close:
$4.82
Open:
$4.83
24h Volume:
1,432,267
Relative Volume:
0.56
Market Cap:
$970.80M
Revenue:
-
Net Income/Loss:
-$129.48M
P/E Ratio:
-
EPS:
-$0.5584
Net Cash Flow:
-$106.97M
1W Performance:
+4.54%
1M Performance:
-1.77%
6M Performance:
-7.71%
1Y Performance:
+13.86%
1-Day Range:
$4.67$4.91
1-Week Range:
$4.67$5.14
52-Week Range:
$3.86$7.01
Savara Inc Stock (SVRA) Company Profile
Name
Savara IncSector
HealthcareIndustry
BiotechnologyPhone
51285113796Address
6836 BEE CAVE ROAD, AUSTIN, TX, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS
Savara Inc Stock (SVRA) Upgrades & Downgrades
Savara Inc Stock (SVRA) Financials Data
Savara Inc Stock (SVRA) Insider Trading
- Lowrance David LJun 22 '26Chief Financial Officer
- Transaction
- Sale
- Cost
- $5.68
- #Shares
- 394,528
- Value ($)
- 2,241,432
- #Shares Total
- 536,032
- Lowrance David LJun 22 '26Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $1.76
- #Shares
- 580,187
- Value ($)
- 1,021,116
- #Shares Total
- 983,947
- Lowrance David LJun 22 '26Officer
- Transaction
- Proposed Sale
- Cost
- $5.65
- #Shares
- 394,528
- Value ($)
- 2,229,000
- #Shares Total
- 0
- Lowrance David LMar 18 '26Chief Financial Officer
- Transaction
- Option Exercise
- Cost
- $1.60
- #Shares
- 366,747
- Value ($)
- 588,455
- #Shares Total
- 552,550
- McCracken Joseph SFeb 16 '26Director
- Transaction
- Option Exercise
- Cost
- $1.76
- #Shares
- 1,807
- Value ($)
- 3,180
- #Shares Total
- 302,644
- RAMSAY DAVID ADec 19 '25Director
- Transaction
- Sale
- Cost
- $6.06
- #Shares
- 20,000
- Value ($)
- 121,220
- #Shares Total
- 2,533,642
- RAMSAY DAVID ADec 18 '25Director
- Transaction
- Proposed Sale
- Cost
- $6.11
- #Shares
- 20,000
- Value ($)
- 122,200
- #Shares Total
- 0
- Elam Nevan CDec 02 '25Director
- Transaction
- Option Exercise
- Cost
- $1.46
- #Shares
- 5,860
- Value ($)
- 8,556
- #Shares Total
- 68,360
- Hawkins Richard JNov 14 '25Director
- Transaction
- Option Exercise
- Cost
- $1.46
- #Shares
- 5,860
- Value ($)
- 8,556
- #Shares Total
- 121,326
